🔴 Indaptus Therapeutics is trading 6.7% down with no clear company-specific catalyst

Indaptus Therapeutics is trading 6.7% lower at $3.07; no clear company-specific announcement explaining the September 29 move was identified.

• Recent coverage points to the previously announced September private placement, which is not new today.
• Supplied price context shows continued weakness after the September 28 close of $3.29, down 14.55%.
• The broad market is only slightly lower; available evidence does not establish it as the cause.